Publication Name	World Journal of Clinical Oncology
Manuscript ID	39548
Country	Mexico

Received	2018-04-27 01:52
Peer-Review Started	2018-04-27 03:23
To Make the First Decision	2018-06-15 02:43
Return for Revision	2018-06-15 03:43
Revised	2018-06-22 05:16
Second Decision	2018-06-28 10:10
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-06-29 01:27
Articles in Press	2018-06-29 01:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2018-08-09 07:20
Publish the Manuscript Online	2018-08-13 07:12

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer
Manuscript Source	Invited Manuscript
All Author List	Angeles C Tecalco-Cruz and Josué O Ramírez-Jarquín
Funding Agency and Grant Number	Funding Agency Grant Number DGAPA-UNAM-PAPIIT IA200916 DGAPA-UNAM-PAPIIT IA201618
Corresponding Author	Angeles C Tecalco-Cruz, PhD, Full Professor, Programa de Investigación de Cáncer de Mama (PICM), Departamento de Biología Moleculary Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad Universitaria, México 04510, Mexico. 12anget@gmail.com
Key Words	Estrogen receptor alpha polyubiquitination; Breast cancer; Estrogen receptor alpha
Core Tip	The inhibition of the estrogen receptor alpha polyubiquitination and degradation by several molecular mechanisms is related to the progression of breast cancer and resistance to endocrine therapy.
Publish Date	2018-08-13 07:12
Citation	Tecalco-Cruz AC, Ramírez-Jarquín JO. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer. World J Clin Oncol 2018; 9(4): 60-70
URL	http://www.wjgnet.com/2218-4333/full/v9/i4/60.htm
DOI	http://dx.doi.org/10.5306/wjco.v9.i4.60

Full Article (PDF)	WJCO-9-60.pdf
Full Article (Word)	WJCO-9-60.doc
Manuscript File	39548-Review.docx
Answering Reviewers	39548-Answering reviewers.pdf
Audio Core Tip	39548-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	39548-Conflict-of-interest statement.pdf
Copyright License Agreement	39548-Copyright assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	39548-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	39548-Language certificate.pdf
Peer-review Report	39548-Peer-review(s).pdf
Scientific Misconduct Check	39548-Scientific misconduct check.pdf
Scientific Editor Work List	39548-Scientific editor work list.pdf